Asghar, K. and Loya, A. 2018. INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS. Journal of Cancer & Allied Specialties. 4, 3 (Sep. 2018). DOI:https://doi.org/10.37029/jcas.v4i3.175.